Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • JUNIPER

    AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144

    View Trial
  • Molecular and Cellular Studies on Inflammation in Multiple Sclerosis

    View Trial
  • NURTuRE – CKD

    National Unified Renal Translational Research Enterprise – Chronic Kidney Disease

    View Trial
  • IELSG 37

    A randomized open label multicentre two-arm phase III comparative study assessing the role of mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed Primary Mediastinal Large B-cell Lymphoma (PMLBCL)

    View Trial
  • CReST2

    CReST2 Colorectal Stenting Trial 2; Uncovered vs covered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting

    View Trial
  • SPARE

    Randomised trial of Selective bladder Preservation Against Radical Excision (cystectomy) in muscle invasive T2/T3 transitional cell carcinoma of the bladder – feasibility study

    View Trial
  • Early access to medicines scheme – nivolumab – for gastric and gastroesophageal junction (GC/GEJ) adenocarcinoma observational study

    View Trial
  • ST03

    A randomised Phase 2/3 trial of perioperative chemotherapy with or without Bevacizumab in operable adenocarcinoma of the stomach and gastro-oesophageal junction

    View Trial
  • ENDCaP-C Test Accuracy Study

    Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis (ENDCaPC) A Multicentre test accuracy study

    View Trial
  • MASCOT

    A study assessing morbidity and portal circulation in patients with Myeloproliferative neoplasms and splanchnic vein thrombosis

    View Trial